Integrating Tobacco Treatment Into Oncology Care: Reach and Effectiveness of Evidence-Based Tobacco Treatment Across National Cancer Institute–Designated Cancer Centers
Journal of Clinical Oncology · 20.05.2023 · 41 (15) · 2756-2766
DOI: 10.1200/jco.22.00936 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Clinical Oncology, erschienen am 20.05.2023. Verfasst von Sarah D Hohl und 30 weiteren Autor:innen. Beteiligte Einrichtung: Carbone Cancer Center, School of Medicine and Public Health, University of Wisconsin-Madison, Madison, WI. Hauptthemen laut MEDLINE: Smoking Cessation, Neoplasms. Die Arbeit wurde bisher 44-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, NCATS NIH HHS, NIGMS NIH HHS.
Abstract (Originalsprache)
PURPOSE Quitting smoking improves patients' clinical outcomes, yet smoking is not commonly addressed as part of cancer care. The Cancer Center Cessation Initiative (C3I) supports National Cancer Institute–designated cancer centers to integrate tobacco treatment programs (TTPs) into routine cancer care. C3I centers vary in size, implementation strategies used, and treatment approaches. We examined associations of these contextual factors with treatment reach and smoking cessation effectiveness. METHODS This cross-sectional study used survey data from 28 C3I centers that reported tobacco treatment data during the first 6 months of 2021. Primary outcomes of interest were treatment reach (reach)—the proportion of patients identified as currently smoking who received at least one evidence-based tobacco treatment component (eg, counseling and pharmacotherapy)—and smoking cessation effectiveness (effectiveness)—the proportion of patients reporting 7-day point prevalence abstinence at 6-month follow-up. Center-level differences in reach and effectiveness were examined by center characteristics, implementation strategies, and tobacco treatment components. RESULTS Of the total 692,662 unique patients seen, 44,437 reported current smoking. Across centers, a median of 96% of patients were screened for tobacco use, median smoking prevalence was 7.4%, median reach was 15.4%, and median effectiveness was 18.4%. Center-level characteristics associated with higher reach included higher smoking prevalence, use of center-wide TTP, and lower patient-to-tobacco treatment specialist ratio. Higher effectiveness was observed at centers that served a larger overall population and population of patients who smoke, reported a higher smoking prevalence, and/or offered electronic health record referrals via a closed-loop system. CONCLUSION Whole-center TTP implementation among inpatients and outpatients, and increasing staff-to-patient ratios may improve TTP reach. Designating personnel with tobacco treatment expertise and resources to increase tobacco treatment dose or intensity may improve smoking cessation effectiveness.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Carbone Cancer Center, School of Medicine and Public Health, University of Wisconsin-Madison, Madison, WI.
- Department of Family Medicine, School of Medicine and Public Health, University of Wisconsin-Madison, Madison, WI.
- Memorial Sloan Kettering Cancer Center, Department of Surgery, Urology Service, New York, NY.
- Department of Health Outcomes and Biomedical Informatics, University of Florida College of Medicine, and University of Florida Health Cancer Center, Gainesville, FL.
- Department of Psychiatry & Behavioral Sciences, Memorial Sloan Kettering Cancer Center, New York, NY.
- Center for Tobacco Research and Intervention, Department of Medicine, University of Wisconsin School of Medicine and Public Health, Madison, WI.
ORCID-Profile: Sarah D Hohl, Richard S Matulewicz, Ramzi G Salloum, Jamie S Ostroff, Robert Schnoll, Steven L Bernstein, Mara Minion, Alex T Ramsey, Kimlin T Ashing, Margaret B Nolan, Jennifer E Bird, Robert T Adsit, Kimberly Shoenbill, Sophia Yeung, Cary A Presant, Lou-Anne Chichester, Li-Shiun Chen
Förderung
- NCI NIH HHS
- NCATS NIH HHS
- NIGMS NIH HHS
Zitieren
APA
Hohl, S. D., Matulewicz, R. S., Salloum, R. G., Ostroff, J. S., Baker, T. B., Schnoll, R., Warren, G., Bernstein, S. L., Minion, M., Lenhoff, K., Dahl, N., Juon, H. S., Tsosie, U., Fleisher, L., D'Angelo, H., Ramsey, A. T., Ashing, K. T., Rolland, B., Nolan, M. B., …, & Chen, L. S. (2023). Integrating Tobacco Treatment Into Oncology Care: Reach and Effectiveness of Evidence-Based Tobacco Treatment Across National Cancer Institute–Designated Cancer Centers. Journal of Clinical Oncology, 41(15), 2756-2766. https://doi.org/10.1200/jco.22.00936
Vancouver
Hohl SD, Matulewicz RS, Salloum RG, Ostroff JS, Baker TB, Schnoll R, et al. Integrating Tobacco Treatment Into Oncology Care: Reach and Effectiveness of Evidence-Based Tobacco Treatment Across National Cancer Institute–Designated Cancer Centers. Journal of Clinical Oncology. 2023;41(15):2756-2766. doi:10.1200/jco.22.00936
BibTeX
@article{Hohl2023,
author = {Hohl, Sarah D and Matulewicz, Richard S and Salloum, Ramzi G and Ostroff, Jamie S and Baker, Timothy B and Schnoll, Robert and Warren, Graham and Bernstein, Steven L and Minion, Mara and Lenhoff, Katie and Dahl, Neely and Juon, Hee Soon and Tsosie, Ursula and Fleisher, Linda and D'Angelo, Heather and Ramsey, Alex T and Ashing, Kimlin T and Rolland, Betsy and Nolan, Margaret B and Bird, Jennifer E and Nguyen, Claire V T and Pauk, Danielle and Adsit, Robert T and Tindle, Hilary A and Shoenbill, Kimberly and Yeung, Sophia and Presant, Cary A and Wiseman, Kara P and Wen, Kuang-Yi and Chichester, Lou-Anne and Chen, Li-Shiun},
title = {Integrating Tobacco Treatment Into Oncology Care: Reach and Effectiveness of Evidence-Based Tobacco Treatment Across National Cancer Institute–Designated Cancer Centers},
journal = {Journal of Clinical Oncology},
year = {2023},
volume = {41},
number = {15},
pages = {2756--2766},
doi = {10.1200/jco.22.00936}
}
EUVIMED